Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

Cited by (518)

Items 101–200 of 518

1. Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta‐Analysis and Systematic Review
   Ambarish Pandey, Sushil Kumar Garg, Susan A. Matulevicius, Amil M. Shah, Jalaj Garg, Mark H. Drazner, Alpesh Amin, Jarett D. Berry, Thomas Hugh Marwick, Steven P. Marso et al. · 2015 · Journal of the American Heart Association
2. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
   Jayanth Ranjit Arnold, Prathap Kanagala, Charley Ann Budgeon, Michael Jerosch‐Herold, Gaurav Singh Gulsin, Anvesha Singh, Jamal Nasir Khan, Daniel C. S. Chan, Iain B Squire, Leong L. Ng et al. · 2022 · JACC. Cardiovascular imaging
3. Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction
   Jennifer E. Ho, Margaret M. Redfield, Gregory D. Lewis, Walter J. Paulus, Carolyn S.P. Lam · 2020 · Circulation
4. Biomarkers of Diastolic Dysfunction and Myocardial Fibrosis: Application to Heart Failure with a Preserved Ejection Fraction
   Michael R. Zile, Catalin F. Baicu · 2013 · Journal of Cardiovascular Translational Research
5. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?
   Pierpaolo Pellicori, Anna Kallvikbacka‐Bennett, Olga Khaleva, Valentina Carubelli, Pierluigi Costanzo, Teresa Castiello, Kenneth Wong, Jufen Zhang, John G.F. Cleland, Andrew L. Clark · 2013 · International journal of cardiac imaging
6. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure
   Anthony G. Garcia, Richard M. Wilson, Joline Heo, Namita R. Murthy, Simoni Baid, Noriyuki Ouchi, Flora Sam · 2012 · American Journal of Physiology-Heart and Circulatory Physiology
7. Left Ventricular Diastolic Dysfunction in the Community: Impact of Diagnostic Criteria on the Burden, Correlates, and Prognosis
   Matthew Gregory Nayor, Leroy Leon Cooper, Danielle M. Enserro, Vanessa Xanthakis, Martin G. Larson, Emelia J. Benjamin, Jayashri R. Aragam, Gary F. Mitchell, Ramachandran Srini Vasan · 2018 · Journal of the American Heart Association
8. Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
   Ravi B. Patel, Carolyn S.P. Lam, Sara Svedlund, Antti Saraste, Camilla Hage, Ru‐San Tan, Lauren Beussink‐Nelson, Jasper Tromp, Cynthia Sanchez, Joyce Nyaucha Njoroge et al. · 2021 · Scientific Reports
9. Effects of Exercise on Left Ventricular Systolic and Diastolic Properties in Patients With Heart Failure and a Preserved Ejection Fraction Versus Heart Failure and a Reduced Ejection Fraction
   Michael R. Zile, Barbro Kjellström, Tom Bennett, Yong Cho, Catalin F. Baicu, Mark F. Aaron, William T. Abraham, Robert C. Bourge, Fred J. Kueffer · 2013 · Circulation Heart Failure
10. Left Ventricular Global Longitudinal Strain in Patients with Heart Failure with Preserved Ejection Fraction: Outcomes Following an Acute Heart Failure Hospitalization
    Jonathan Buggey, Fawaz Abdulaziz M. Alenezi, Hyun Ju Yoon, Matthew Phelan, Adam D. DeVore, Michel Georges Khouri, Phillip J. Schulte, Eric J. Velazquez · 2017 · ESC Heart Failure
11. Heart Failure with Mid-Range Ejection Fraction: Characterization of Patients from the PINNACLE Registry®
    Nasrien E. Ibrahim, Yang Song, Christopher Paul Cannon, Gheorghe D. Doros, Patrícia A. Russo, Angelo Ponirakis, Claire C. Alexanian, James L. Januzzi · 2019 · ESC Heart Failure
12. Histamine H 2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk
    Peter J. Leary, Ryan James Tedford, David A. Bluemke, Michael R. Bristow, Susan R. Heckbert, Steven M. Kawut, Eric V. Krieger, João A.C. Lima, Carolina S. Masri, David D. Ralph et al. · 2016 · Journal of the American College of Cardiology
13. Prospective association between handgrip strength and cardiac structure and function in UK adults
    Sebastian E. Beyer, Mihir M. Sanghvi, Nay Aung, Alice Hosking, Jackie A. Cooper, José Miguel Paiva, Aaron Mark Lee, Kenneth Fung, Elena I. Lukaschuk, Valentina Carapella et al. · 2018 · PLoS ONE
14. Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
    Julian Friebel, Alice Weithäuser, Marco Witkowski, Bernhard Hermann Rauch, Konstantinos Savvatis, Andrea Dörner, Termeh Tabaraie, Mario Kašner, Verena Moos, Diana Bösel et al. · 2019 · European Heart Journal
15. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction
    Nicole Martin, Karthick Manoharan, Ceri Davies, R Thomas Lumbers · 2021 · Cochrane Database of Systematic Reviews
16. Global Longitudinal Strain Predicts Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
    Alison M. Brann, James E. Miller, Emily A. Eshraghian, Jin Joo Park, Barry Greenberg · 2023 · European Journal of Heart Failure
17. Signal Regulatory Protein-α Protects Against Cardiac Hypertrophy Via the Disruption of Toll-Like Receptor 4 Signaling
    Ding‐Sheng Jiang, Xiaofei Zhang, Lu Gao, Jing Zong, Heng Zhou, Yu Liu, Yan Zhang, Zhou‐Yan Bian, Lihua Zhu, Guo‐Chang Fan et al. · 2013 · Hypertension
18. Factors Associated With Left Atrial Remodeling in the General Population
    Walter Oliver, Gwendolyn Matthews, Colby R. Ayers, Sonia Garg, Sachin Gupta, Ian J. Neeland, Mark H. Drazner, Jarett D. Berry, Susan A. Matulevicius, James A. de Lemos · 2017 · Circulation Cardiovascular Imaging
19. Response to Endurance Exercise Training in Older Adults with Heart Failure with Preserved or Reduced Ejection Fraction
    Ambarish Pandey, Dalane W. Kitzman, Peter H. Brubaker, Mark J. Haykowsky, Timothy M. Morgan, J. Thomas Becton, Jarett D. Berry · 2017 · Journal of the American Geriatrics Society
20. Diastolic Determinants of Excess Mortality in Heart Failure With Reduced Ejection Fraction
    Giovanni Benfari, Wayne L. Miller, Clémence Antoine, Andrea Rossi, Grace Lin, Jae K. Oh, Veronique Lee Roger, Prabin Bikram Thapa, Maurice L. Enriquez-Sarano · 2019 · JACC Heart Failure
21. Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction
    Tanaka, Komei, Valero-Muñoz, María, Wilson, Richard M., Essick, Eric E., Fowler, Conor T., Nakamura, Kazuto, van den Hoff, Maurice, Ouchi, Noriyuki, Sam, Flora · 2016 · JACC Basic to Translational Science
22. Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials
    Xinye Li, Yanda Li, Tiansong Zhang, Xingjiang Xiong, Nian Liu, Bing Pang, Yanfei Ruan, Yonghong Gao, Hongcai Shang, Yanwei Xing · 2019 · Pharmacological Research
23. Obesity-Related Heart Failure with Preserved Ejection Fraction
    Tomonari Harada, Masaru Obokata · 2020 · Heart Failure Clinics
24. Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges
    Mads Jønsson Andersen, Barry A. Borlaug · 2014 · Current Cardiology Reports
25. ST2 in heart failure with preserved and reduced ejection fraction
    Emil Najjar, Ulrika Ljung Faxén, Camilla Hage, Erwan Donal, Jean‐Claude Daubert, Cecilia Marianne Linde, Lars H. Lund · 2019 · Scandinavian Cardiovascular Journal
26. Mechanisms of Diastolic Dysfunction in Heart Failure With a Preserved Ejection Fraction
    Martin M. LeWinter, Markus Meyer · 2013 · Circulation Heart Failure
27. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
    Prathap Kanagala, Jayanth Ranjit Arnold, Adrian S. H. Cheng, Anvesha Singh, Jamal Nasir Khan, Gaurav Singh Gulsin, Jing Yang, Lei Zhao, Pankaj Gupta, Iain B Squire et al. · 2019 · International journal of cardiac imaging
28. Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome
    André La Gerche, Erin J. Howden, Mark J. Haykowsky, Gregory D. Lewis, Benjamin D. Levine, Jason Ciril Kovacic · 2022 · Journal of the American College of Cardiology
29. The role of 3D wall motion tracking in heart failure
    Yiu‐fai Cheung · 2012 · Nature Reviews Cardiology
30. The Role of Echocardiography in Heart Failure with Preserved Ejection Fraction
    Masaru Obokata, Yogesh N.V. Reddy, Barry A. Borlaug · 2019 · Heart Failure Clinics
31. Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation
    Sophie Deckx, Ward Heggermont, Paolo Carai, Marieke Rienks, Tom Dresselaers, Uwe Himmelreich, Rick E.W. van Leeuwen, Wies Lommen, Jolanda van der Velden, Arantxa González et al. · 2017 · Matrix Biology
32. NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
    James P. Teuber, Kobina Essandoh, Scott L. Hummel, Nageswara R. Madamanchi, Matthew J. Brody · 2022 · Antioxidants
33. Spironolactone in Patients With an Echocardiographic HFpEF Phenotype Suggestive of Cardiac Amyloidosis
    Brett Wesley Sperry, Mazen A Hanna, Sanjiv Jayendra Shah, Wael A. Jaber, John A. Spertus · 2021 · JACC Heart Failure
34. Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction
    Erwan Donal, Lars H. Lund, Emmanuel Oger, Christian Bosseau, Amélie J. Reynaud, Camilla Hage, Élodie Drouet, Jean‐Claude Daubert, Cecilia Marianne Linde, on behalf of the KaRen Investigators · 2017 · European Heart Journal - Cardiovascular Imaging
35. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study
    Erwan Donal, Lars H. Lund, Emmanuel Oger, Camilla Hage, Hans Persson, Amélie J. Reynaud, Pierre‐Vladimir Ennezat, Fabrice Bauer, Catherine Sportouch, Élodie Drouet et al. · 2014 · Archives of cardiovascular diseases
36. Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
    Alexander Peikert, Marianna Fontana, Scott David Solomon, Thomas Thum · 2025 · European Heart Journal
37. Left Atrial Enlargement in the Early Stage of Hypertensive Heart Disease: A Common But Ignored Condition
    Guanhua Su, Heng Cao, Sudan Xu, Yongxin Lu, Xinxin Shuai, Yufei Sun, Yuhua Liao, Jingdong Li · 2014 · Journal of Clinical Hypertension
38. Atrial Remodelling in Heart Failure: Recent Developments and Relevance for Heart Failure with Preserved Ejection Fraction
    Felix Hohendanner, Daniel Messroghli, David Bode, Florian Blaschke, Abdul Shokor Parwani, Leif‐Hendrik Boldt, Frank R. Heinzel · 2018 · ESC Heart Failure
39. Impaired myocardial work efficiency in heart failure with preserved ejection fraction
    Antonello D’Andrea, Federica Ilardi, Flavio D’Ascenzi, Francesco Bandera, Giovanni Benfari, Roberta Esposito, Alessandro Malagoli, Giulia Elena Mandoli, Ciro Santoro, Vincenzo Russo et al. · 2021 · European Heart Journal - Cardiovascular Imaging
40. Invasive Hemodynamic Characterization of Heart Failure with Preserved Ejection Fraction
    Mads Jønsson Andersen, Barry A. Borlaug · 2014 · Heart Failure Clinics
41. Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction
    Ross T. Campbell, John J.V. McMurray · 2014 · Heart Failure Clinics
42. Myosin Cross-Bridge Dynamics in Patients With Hypertension and Concentric Left Ventricular Remodeling
    Cam Donaldson, Bradley M. Palmer, Michael R. Zile, David W. Maughan, John S. Ikonomidis, Henk L. M. Granzier, Markus Meyer, Peter VanBuren, Martin M. LeWinter · 2012 · Circulation Heart Failure
43. The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure
    Benjamin Werbner, Omid Mohammad Tavakoli‐Rouzbehani, Amir Nima Fatahian, Sihem Boudina · 2023 · The Journal of Cardiovascular Aging
44. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
    Chris J. Kapelios, Jonathan R. Murrow, Thomas Georg Nührenberg, Maria N. Montoro Lopez · 2019 · Heart Failure Reviews
45. Diagnostic scores predict morbidity and mortality in patients hospitalized for heart failure with preserved ejection fraction
    Frederik Hendrik Verbrugge, Yogesh N.V. Reddy, Hidemi Sorimachi, Kazunori Omote, Rickey E. Carter, Barry A. Borlaug · 2021 · European Journal of Heart Failure
46. Myocardial reverse remodeling: how far can we rewind?
    Patrícia Gonçalves‐Rodrigues, Adelino Ferreira Leite-Moreira, Inês Falcão‐Pires · 2016 · American Journal of Physiology-Heart and Circulatory Physiology
47. Growth Arrest–Specific 6 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy
    Yifan Zhao, Dachun Xu, Guofu Zhu, Mengyun Zhu, Kai Tang, Wei‐Ming Li, Yawei Xu · 2015 · Hypertension
48. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
    Constantijn Franssen, H. Sophia Chen, Nazha Hamdani, Walter J. Paulus · 2015 · Heart
49. Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
    Ramesh Ratanlal Dargad, Mahesh R. Prajapati, Dargad Rohit R, Jai D. Parekh · 2018 · Indian Heart Journal
50. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
    Przemysław Jacek Kotyla · 2018 · International Journal of Molecular Sciences
51. Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
    Robert J. Henning · 2019 · World Journal of Cardiology
52. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach
    Prathap Kanagala, Jayanth Ranjit Arnold, Anvesha Singh, Daniel C. S. Chan, Adrian S. H. Cheng, Jamal Nasir Khan, Gaurav Singh Gulsin, Jing Yang, Lei Zhao, Pankaj Gupta et al. · 2020 · PLoS ONE
53. LCZ 696 (Valsartan/Sacubitril) – A Possible New Treatment for Hypertension and Heart Failure
    Mathilde Borring Andersen, Ulf Simonsen, Markus Wehland, Jessica Pietsch, Daniela G. Grimm · 2015 · Basic & Clinical Pharmacology & Toxicology
54. WHO's in Second?
    Sif Hansdóttir, Dayna J. Groskreutz, Brian K. Gehlbach · 2013 · CHEST Journal
55. Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction
    John G.F. Cleland, Pierpaolo Pellicori, Riet Dierckx · 2014 · Heart Failure Clinics
56. Left Atrial Function and Maximal Exercise Capacity in Heart Failure with Preserved and Mid-Range Ejection Fraction
    Caterina Maffeis, Daniel Armando Morris, Evgeny Belyavskiy, Martin Kropf, Aravind Kumar Radhakrishnan, Veronika Zach, Cristina Rozados da Conceicao, Tobias Daniel Trippel, Elisabeth Pieske‐Kraigher, Andrea Rossi et al. · 2020 · ESC Heart Failure
57. Defining Diastolic Heart Failure and Identifying Effective Therapies
    John G.F. Cleland, Pierpaolo Pellicori · 2013 · JAMA
58. Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction
    Tomonari Harada, Kazuki Kagami, Toshimitsu Kato, Masaru Obokata · 2021 · Journal of Cardiology
59. Impact of Coronary Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: A Meta-Analysis
    Domenico D’Amario, Renzo Laborante, Emiliano Bianchini, Giuseppe Ciliberti, Donato Antonio Paglianiti, Mattía Galli, Attilio Restivo, Davide Stolfo, Rocco Vergallo, Giuseppe M.C. Rosano et al. · 2024 · ESC Heart Failure
60. Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction — Results of the Aldo-DHF trial
    Frank Edelmann, Götz Gelbrich, André Duvinage, Raoul Stahrenberg, Anneke Behrens, Christiane Prettin, Elisabeth Kraigher‐Krainer, Albrecht G. Schmidt, Hans‐Dirk Düngen, W. Kamke et al. · 2013 · International Journal of Cardiology
61. Age- and Sex-Related Differences in Diastolic Function and Cardiac Dimensions in a Hypertensive Population
    Shiro Hoshida, Yukinori Shinoda, Kuniyasu Ikeoka, Hidetada Fukuoka, Hirooki Inui, Tetsuya Watanabe · 2016 · ESC Heart Failure
62. Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model ( Ttn ΔIAjxn )
    Mathew M. Bull, Mei Methawasin, Joshua G. Strom, Pooja Nair, Kirk R. Hutchinson, Henk L. M. Granzier · 2016 · Circulation Research
63. Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis
    Xuanyi Jin, Jan F. Nauta, Chung‐Lieh Hung, Wouter Ouwerkerk, Tiew‐Hwa Katherine Teng, Adriaan A. Voors, Carolyn S.P. Lam, Joost P. van Melle · 2022 · Heart Failure Reviews
64. Phenotyping heart failure by echocardiography: imaging of ventricular function and haemodynamics at rest and exercise
    Otto Armin Smiseth, Erwan Donal, Espen Boe, Jong‐Won Ha, João Filipe Fernandes, Pablo Lamata · 2023 · European Heart Journal - Cardiovascular Imaging
65. Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions
    Bharathi Upadhya, Mark J. Haykowsky, Dalane W. Kitzman · 2018 · Heart Failure Reviews
66. Heart failure: What does ejection fraction have to do with it?
    Hiroyuki Iwano, William C. Little · 2013 · Journal of Cardiology
67. Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
    Bence Hegyi, Juliana Mira Hernández, Christopher Y. Ko, Junyoung Hong, Erin Y. Shen, Emily R. Spencer, Daria Smoliarchuk, Manuel F. Navedo, Donald M. Bers, Julie Bossuyt · 2022 · Journal of the American Heart Association
68. HFpEF: Cardiovascular Abnormalities Not Just Comorbidities
    William C. Little, Michael R. Zile · 2012 · Circulation Heart Failure
69. Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options
    Yves Juillière, Clément Venner, Laura Filippetti, Batric Popovic, Olivier Huttin, Christine Selton‐Suty · 2018 · Archives of cardiovascular diseases
70. Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach
    Antoni Bayés‐Genís, Felipe Bisbal, Julio E. Núñez, Enrique Santas, Josep Lupón, Patrick Rossignol, Walter J. Paulus · 2020 · Journal of Clinical Medicine
71. Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
    Prasad C. Gunasekaran, Sidakpal Panaich, Αlexandros Briasoulis, Shaun J. Cardozo, Luis Afonso · 2016 · Current Cardiology Reviews
72. Left atrial size and heart failure hospitalization in patients with diastolic dysfunction and preserved ejection fraction
    Omar Issa, Julio Gabriel Peguero, Carlos Alberto Podesta, Denisse Diaz, Javier De La Cruz, Daniela Pírela, JuanCarlos Brenes · 2017 · Journal of Cardiovascular Echography
73. Risk Stratification with Echocardiographic Biomarkers in Heart Failure with Preserved Ejection Fraction: The Media Echo Score
    Olivier Huttin, Alan G. Fraser, Lars H. Lund, Erwan Donal, Cecilia Marianne Linde, Masatake Kobayashi, Tamás Erdei, Jean‐Loup Machu, Kévin Duarte, Patrick Rossignol et al. · 2021 · ESC Heart Failure
74. Diastolic heart failure: What we still don’t know
    Carsten Tschöpe, Carolyn S.P. Lam · 2012 · Herz
75. Age, Gender and Load-Related Influences on Left Ventricular Geometric Remodeling, Systolic Mid-Wall Function, and NT-ProBNP in Asymptomatic Asian Population
    Chi Chen, Kuo‐Tzu Sung, Shou‐Chuan Shih, Chuanchuan Liu, Jen‐Yuan Kuo, Charles Jia‐Yin Hou, Chung‐Lieh Hung, Hung‐I Yeh · 2016 · PLoS ONE
76. Prognostic Impacts of Dynamic Cardiac Structural Changes in Heart Failure Patients with Preserved Left Ventricular Ejection Fraction
    Shinsuke Yamanaka, Yasuhiko Sakata, Kotaro Nochioka, Masanobu Miura, Shintaro Kasahara, Masayuki Sato, Hajime Aoyanagi, Takahide Fujihashi, Hideka Hayashi, Takashi Shiroto et al. · 2020 · European Journal of Heart Failure
77. Heart failure with preserved ejection fraction.
    Marzia Rigolli, GILLIAN A. WHALLEY · 2013 · Europe PMC (PubMed Central)
78. Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study
    Daisuke Kamimura, Takeki Suzuki, Wanmei Wang, Matthew D deShazo, John Edward Hall, Michael D. Winniford, Iftikhar J. Kullo, Thomas H. Mosley, Kenneth R. Butler, Michael E. Hall · 2018 · Hypertension Research
79. Pharmacological interventions for heart failure in people with chronic kidney disease
    Meaghan Lunney, Marinella Ruospo, Patrizia Natale, Robert Ross Quinn, Paul Everett Ronksley, Ioannis Konstantinidis, Suetonia C. Palmer, Marcello A. Tonelli, Giovanni FM Strippoli, Pietro Ravani · 2020 · Cochrane Database of Systematic Reviews
80. The contribution of comorbidities to mortality in hospitalized patients with heart failure
    Oliver Riedel, Christoph Ohlmeier, Dirk Enders, Albrecht Elsässer, David Vizcaya, Alexander Michel, Sveja Eberhard, Natasha I. Schlothauer, J. Berg, Edeltraut Garbe · 2018 · Clinical Research in Cardiology
81. Prognostic significance of red cell distribution width and its relation to increased pulmonary pressure and inflammation in acute heart failure
    Ryszard Targoński, Janusz Sadowski, Magdalena Starek-Stelmaszczyk, Radosław Targoński, Andrzej Rynkiewicz · 2018 · Cardiology Journal
82. Clinical significance of serum magnesium levels in patients with heart failure with preserved ejection fraction
    Taiki Nishihara, Eiichiro Yamamoto, Daisuke Sueta, Koichiro Fujisue, Hiroki Usuku, Fumi Oike, Masafumi Takae, Yuichiro Arima, Satoshi Araki, Seiji Takashio et al. · 2019 · Medicine
83. Left atrial rather than left ventricular impaired mechanics are associated with the pro‐fibrotic ST 2 marker and outcomes in heart failure with preserved ejection fraction
    Anikó Ilona Nagy, Camilla Hage, Béla Péter Merkely, Erwan Donal, Jean‐Claude Daubert, Cecilia Marianne Linde, Lars H. Lund, Aristomenis Manouras · 2018 · Journal of Internal Medicine
84. Echocardiographic Predictors of Cardiovascular Outcome in Heart Failure with Preserved Ejection Fraction
    Nelson Wang, Phidias Rueter, Melvin Ng, Sashiruben Chandramohan, Thomas Hibbert, John O’Sullivan, David M. Kaye, Sean Lal · 2024 · European Journal of Heart Failure
85. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center
    Iwona Świątkiewicz, Neeja Patel, MaryAnn Villarreal-Gonzalez, Pam R. Taub · 2024 · BMC Medicine
86. Cardiac Radionuclide Imaging to Assess Patients With Heart Failure
    Mark I. Travin · 2014 · Seminars in Nuclear Medicine
87. Heart rate-induced modifications of concentric left ventricular hypertrophy: exploration of a novel therapeutic concept
    Franziska J. Klein, Stephen Bell, K. Elisabeth Runte, Robert M. Lobel, Takamuru Ashikaga, Lilach O. Lerman, Martin M. LeWinter, Markus Meyer · 2016 · American Journal of Physiology-Heart and Circulatory Physiology
88. Device-based treatment options for heart failure with preserved ejection fraction
    Chihiro Miyagi, Takuma Miyamoto, Jamshid H. Karimov, Randall C. Starling, Kiyotaka Fukamachi · 2021 · Heart Failure Reviews
89. Renin overexpression leads to increased titin-based stiffness contributing to diastolic dysfunction in hypertensive mRen2 rats
    Árṕad Kov́acs, Gábor Áron Fülöp, Andrea Kovács, Tamás Csípő, Beáta Bódi, Dániel Priksz, Béla Juhász, Lívia Beke, Zoltán Hendrik, Gábor Méhes et al. · 2016 · American Journal of Physiology-Heart and Circulatory Physiology
90. Interrelation between heart failure with preserved ejection fraction and renal impairment
    Jennifer Ruth Joslin, Eirini Lioudaki, Emmanuel S. Androulakis · 2022 · Reviews in Cardiovascular Medicine
91. Should We Test for Diastolic Dysfunction? How and How Often?
    Sheldon E. Litwin, Michael R. Zile · 2019 · JACC. Cardiovascular imaging
92. Serotonin release in nucleus of the solitary tract and its modulation by antitussive drugs.
    Junzo Kamei, Tadashi Mori, H Igarashi, Y Kasuya · 1992 · PubMed
93. Causes and Pathophysiology of Heart Failure with Preserved Ejection Fraction
    Árṕad Kov́acs, Zoltán Papp, László Nagy · 2014 · Heart Failure Clinics
94. Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
    Chim Choy Lang, Jagdeep S. Singh · 2015 · Vascular Health and Risk Management
95. Temperature and transmural region influence functional measurements in unloaded left ventricular cardiomyocytes
    Charles S. Chung, Kenneth S. Campbell · 2013 · Physiological Reports
96. Left atrial changes in early stages of heart failure with preserved ejection fraction
    Ibadete Bytyçi, Gani Bajraktari · 2016 · Echocardiography
97. Low Natriuretic Peptide Levels and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction
    Toru Kondo, Ross T. Campbell, Pardeep S. Jhund, Inder S. Anand, Peter E. Carson, Carolyn S.P. Lam, Sanjiv Jayendra Shah, Muthiah Vaduganathan, Faiez M. Zannad, Michael R. Zile et al. · 2024 · JACC Heart Failure
98. Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction – A report from the Japanese Diastolic Heart Failure Study (J-DHF)
    Kazuhiro Yamamoto, Hideki Origasa, Yasushi A Suzuki, Toshiaki Takahashi, Tsuyoshi Shinozaki, Tomoyuki Watanabe, Yasushi Sakata, Chisato Izumi, Kayano Taira, Masatsugu Hori · 2013 · Journal of Cardiology
99. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials
    Hidekatsu Fukuta, Toshihiko Goto, Kazuaki Wakami, Takeshi Kamiya, Nobuyuki Ohte · 2018 · Heart and Vessels
100. Aldosterone dysregulation predicts the risk of mortality and rehospitalization in heart failure with a preserved ejection fraction
     Bingbing Ke, Xin Tan, Lu Ren, Yang-Kai Fan, Yixin Zhang, Fengjuan Li, Qiqi Sun, Tong Liu, Lixin Jia, Yuan Wang et al. · 2021 · Science China Life Sciences